New Horizons in Primary Biliary Cholangitis: Integrating Patient Experiences and Therapeutic Advances to Improve Care

New Horizons in Primary Biliary Cholangitis: Integrating Patient Experiences and Therapeutic Advances to Improve Care

Primary biliary cholangitis (PBC) is a progressive disease with substantial symptom burden and impact on quality of life. Presently, there are multiple new and emerging therapies poised to transform the pharmacologic management of PBC. Tune in to this dynamic presentation to hear two leading PBC experts explore patient-centered and evidence-based approaches to the treatment of this highly heterogenous condition. This webcast of a live webinar will feature testimonials from patients with PBC, use animation to depict the mechanisms of action of novel therapies, and explore clinical applications of rapidly evolving evidence. This activity is delivered in partnership with the Global Liver Institute.

  • Provider:PRIME Education, Inc. (PRIME®)
  • Activity Link: https://primeinc.org/online/accelerating-adoption-emerging-therapies-patient-centric-approaches-at
  • Start Date: 2024-12-05 06:00:00
  • End Date: 2024-12-05 06:00:00
  • Credit Details: AAPA Category 1 Credit™️: 1.0 hours
    AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
    Pharmacy: 1.0 hours
  • MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: Source: Gilead Sciences, Inc. - Amount: 50000.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Gastroenterology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.